DOI: 10.4244/EIJ-D-20-00621L

Letter: Cardiac CT prior to percutaneous coronary sinus-based mitral annuloplasty with the Carillon device

Michał Kuzemczak1,2, MD, PhD, MSc; Tomasz Siminiak2, MD, PhD

We read with great interest the article by Rottländer et al entitled “CT-Angiographic imaging of the Carillon device topography after unsuccessful treatment of FMR”1, suggesting that parameters such as coronary sinus (CS) to mitral valve annulus distance and angle might predict response to Carillon device implantation. However, the measurements were obtained nine months following the procedure when they might not reflect native preprocedural anatomical relationships. The Carillon device applies tension on the vein and frequently alters relations between adjacent structures. As an example, the vein can be displaced by the device which causes the artery to be no longer compressed, despite the preprocedural computed tomography (CT) showing otherwise. The AMADEUS trial also revealed no significant differences between responders and non-responders in terms of the position of the venous system in relation to the posterior mitral annulus2. Furthermore, counter-intuitively, the Carillon device was also effective when the coronary sinus and great cardiac vein were located above the plane of the mitral annulus. Given the above, a CT scan was no longer mandatory in later clinical trials which, in our belief, does not imply complete uselessness of the imaging technique.

Analysis of our own series of cases has shown that only the tenting area assessed by preprocedural echocardiography was correlated with the degree of improvement after Carillon implantation3. While we agree that cardiac CT has potential to yield important preprocedural data for planning and facilitating the procedure, assessment of the effect of reciprocal annular-CS relations by CT on the procedural results requires verification in a clinical trial. Rottländer et al should be congratulated for the excellent presentation of relevant measurements.

Conflict of interest statement

T. Siminiak was a proctor and an investigator in clinical trials sponsored by Cardiac Dimensions, Inc., and received personal fees from Cardiac Dimensions, Inc., during the conduct of the study. The other author has no conflicts of interest to declare.

Supplementary data

To read the full content of this article, please download the PDF.

Volume 16 Number 10
Nov 20, 2020
Volume 16 Number 10
View full issue


Key metrics

Suggested by Cory

Image – Interventional flashlight

10.4244/EIJ-D-20-00332 Mar 19, 2021
Computed tomography angiography imaging of the Carillon device topography after unsuccessful treatment of functional mitral regurgitation
Rottländer D et al
free

MITRAL VALVE INTERVENTIONS

10.4244/EIJV12SYA16 Sep 18, 2016
The Carillon: strategies for optimal patient selection and optimised results
Rottlaender D et al
free

10.4244/EIJV11SWA18 Sep 17, 2015
The CARILLON Mitral Contour transcatheter indirect mitral valve annuloplasty system
Goldberg S et al
free

MITRAL VALVE INTERVENTIONS

10.4244/EIJV12SYA17 Sep 18, 2016
The Mitralign: strategies for optimal patient selection and optimised results
Schueler R and Nickenig G
free
Trending articles
310.43

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.2

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76.25

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
28

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved